HYTN anticipates the arrival of the initial cultivation batches for GMP processing in Q2 2025, with the first shipments to ...

Cannabis can yield miracle drugs to beat anxiety, pains etc’ Sanjeev K Sharma JAMMU, Mar 28: Scientists at a pioneer research ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

Micro, small and medium enterprises (MSMEs) with revenue of less than ₹ 250 crore have to submit an application before the ...

She pointed out that several of these factories lacked pallets for stacking their finished products, and some did not have a ...

Pharmaceutical warehousing is not just about storing products; it’s a critical part of the supply chain that ensures the ...

Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA ...

Saint-Beauzire Facility Saint-Beauzire Production Line for both liquid and lyophilized forms BUBENDORF, Switzerland, March 24 ...

The project will be an extension of the CDSCO and NIHFW's ongoing training programmes with drug inspectors from the central ...

CRL focused on CMC; no clinical issues relating to etripamil raised $69.7M in cash, cash equivalents and short-term investments as of December 31, 2024 MONTREAL and CHARLOTTE, N.C., March 28, 2025 ...

The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...

Milestone Pharmaceuticals (MIST) announced the U.S. Food and Drug Administration, FDA, issued a Complete Response Letter, CRL, regarding its ...